Archives: News

Treventis VP Research Dr. Marcia Taylor was an invited speaker at the Targeting Protein Misfolding Summit, held virtually from March 15-17, 2021. […]

Dr. Marcia Taylor was in attendance at the virtual AD/PD conference taking that took place on March 9-14, 2021. This event specializes […]

Treventis scientists Drs. Christopher Barden and Ross Mancini and SAB member Dr. Janice Robertson attended the 31st Virtual International Symposium on ALS/MND […]

Treventis was well represented at the Alzheimer Association International Conference, running from Jul 27-31, 2020 (originally scheduled for Amsterdam, the Netherlands, and […]

LifeArc, a major UK-based charity, has announced funding for Treventis founders Dr. Donald Weaver, Christopher Barden, and Mark Reed to perform a […]

Not to be deterred by COVID-19, Treventis attended the BIO Digital International Convention (formerly scheduled for San Diego, California; instead held digitally) […]

Treventis CSO Mark Reed was in attendance at the 8th Neurodegenerative Drug Development Summit (previously known as World CNS) held in Boston, […]

Treventis VP Research Marcia Taylor has attended Tau2020 in Washington, DC, which is one of the world’s biggest conferences focusing on tau: […]

Treventis founders Dr. Donald Weaver, Mark Reed, and Christopher Barden have supervised research at Toronto hospital UHN into new methods for predicting […]

Treventis CEO Christopher Barden attended BioPort, Atlantic Canada’s largest health and life sciences event in Halifax, Nova Scotia. BioPort is the region’s […]